[Federal Register Volume 64, Number 111 (Thursday, June 10, 1999)]
[Notices]
[Pages 31224-31226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-14700]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[Program Announcement 99145]


Hepatitis Education for Inmates and Correctional Staff; Notice of 
Availability of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 1999 funds for a cooperative agreement 
with one or more national voluntary organizations involved with 
correctional facilities to develop and distribute materials to educate 
inmates and correctional staff about the risks of transmission and 
acquisition of viral hepatitis, as well as prevention, counseling, 
testing, and treatment of viral hepatitis, with an emphasis on 
hepatitis A, B, and C prevention and counseling. This program addresses 
the ``Healthy People 2000'' priority area of Immunization and 
Infectious Diseases.
    The purpose of the program is to provide assistance for the 
development of educational materials that address the prevention, 
testing, counseling, and treatment of viral hepatitis (focus on the 
prevention of hepatitis A, B, and C virus infection including hepatitis 
B vaccination) in correctional settings in the United States. 
Specifically, applications are solicited for projects aimed at 
developing and distributing educational materials on viral hepatitis to 
inmates, and correctional staff.

B. Eligible Applicants

    Applications may be provided only to organizations currently 
providing health education materials to correctional populations and 
health related training materials to staff of correctional institutions 
at a national or regional level.
    Since the purpose of the program is to provide assistance for the 
development of educational materials that address the prevention, 
testing, counseling, and treatment of viral hepatitis in correctional 
settings in the United States, only applications from organizations 
that develop and distribute educational materials on viral hepatitis to 
inmates and correctional staff are solicited.

    Note: Public Law 104-65 states that an organization described in 
section 501(c)(4) of the Internal Revenue Code of 1986 that engages 
in lobbying activities is not eligible to receive Federal funds 
constituting an award, grant, cooperative agreement, contract, loan, 
or any other form.

C. Availability of Funds

    Approximately $100,000 is available in FY 1999 to fund up to 3 
awards. It is expected that the average award will be $35,000, ranging 
from $25,000 to $40,000. It is expected that the award(s) will begin on 
or about September 30, 1999, and will be made for a 12-month budget 
period within a project period of up to three years. Funding estimates 
may change.
    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress as evidenced by required reports 
and the availability of funds.

Funding Preference

    A preference will be given to applicants with access to inmates and 
corrections staff at local, state, and/or federal (public and private) 
corrections programs with a demonstrated high concentration of inmates 
and corrections staff at high risk for viral hepatitis infection.

D. Program Requirements

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities under 1. below, 
and CDC will be

[[Page 31225]]

responsible for the activities listed under 2. below:
    1. Recipient Activities.
    a. Conduct a needs assessment to demonstrate a genuine and 
compelling need for educational materials for inmates and correctional 
staff. At the conclusion of the needs assessment, begin to develop 
appropriate educational materials.
    b. Develop educational materials on prevention, testing, 
counseling, and treatment for inmates in all types of correctional 
settings. The applicant may include formative research and focus group 
testing of materials. The central focus of these educational materials 
should be the prevention of hepatitis A, B, and C virus infection 
including hepatitis B vaccination.
    c. Develop appropriate materials specific to the needs of this 
inmate and correctional staff population and correlate with the needs 
assessment done in the first year.
    d. Develop an inmate education curriculum emphasizing risk-
reduction, specific to the prevention of viral hepatitis.
    e. Evaluate the program established to determine pre- and post-
education knowledge about the prevention of hepatitis.
    2. CDC Activities.
    a. Provide technical information for all forms of viral hepatitis 
including information about current testing, modes of transmission, 
treatment, vaccinations, and complications.
    b. Provide assistance in the development and distribution of the 
educational materials for both inmates and correctional staff.
    c. Provide the source of information for these educational 
materials.
    d. Assist in the development of a research protocol for IRB review 
by all cooperating institutions participating in the research project. 
The CDC IRB will review and approve the protocol initially an or at 
least on an annual basis until the research project is completed.

E. Application Content

    Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated on the criteria 
listed, so it is important to follow them in laying out your program 
plan. The narrative should be no more than 20 double-spaced pages, 
printed on one side, with one inch margins, and unreduced 12 cpi font.
    Include the following in the narrative section of your application:
    1. Program objectives that respond to the program requirements 
outlined in this announcement.
    2. An operational plan that describes how the objectives will be 
achieved.
    3. An evaluation plan that includes qualitative and quantitative 
measures to assess the effectiveness of the program in accomplishing 
your program objectives.
    4. A projected time line for conducting the proposed program and 
evaluation activities.
    5. A description of personnel that includes current and proposed 
staff with position titles, position descriptions, and percentage of 
time staff person will devote to assigned project responsibilities. 
Also, include a curriculum vitae of new staff.
    6. A detailed, line-item budget for the project and a budget 
narrative that justifies each line-item.

F. Submission and Deadline

    Submit the original and two copies of PHS 5161-1 (OMB Number 0937-
0189). Forms are available in the application kit. On or before July 
23, 1999, submit the application to the Grants Management Specialist 
identified in the ``Where to Obtain Additional Information'' section of 
this announcement.
    Deadline: Applications shall be considered as meeting the deadline 
if they are either:
    (a) Received on or before the deadline date; or
    (b) Sent on or before the deadline date and received in time prior 
to the submission to the review panel. (Applicants must request a 
legibly dated U.S. Postal Service postmark or obtain a legibly dated 
receipt from a commercial carrier or U.S. Postal Service. Private 
metered postmarks shall not be acceptable as proof of timely mailing.)
    Late Applications: Applications which do not meet the criteria in 
(a) or (b) above are considered late applications, will not be 
considered, and will be returned to the applicant.

G. Evaluation Criteria

    Each application will be evaluated individually against the 
following criteria by an independent review group appointed by CDC.

1. Objectives

    The degree to which the project objectives are capable of achieving 
the specific requirements defined in the program announcement. (25 
points)

2. Plan

    The degree to which the proposed activities described in the plan 
of operation, if well executed, are capable of attaining project 
objectives. The degree to which the applicant has met the CDC Policy 
requirements regarding the inclusion of women, ethnic, and racial 
groups in the proposed research. This includes: (a) The proposed plan 
for the inclusion of both sexes and racial and ethnic minority 
populations for appropriate representation, (b) the proposed 
justification when representation is limited or absent, (c) a statement 
as to whether the design of the study is adequate to measure 
differences when warranted, and (d) a statement as to whether the plans 
for recruitment and outreach for study participants include the process 
of establishing partnerships with community(ies) and recognition of 
mutual benefits. (25 points)

3. Evaluation

    The degree to which the proposed plan of evaluation will adequately 
measure the objectives. (10 points)

4. Staff

    The degree to which the current and proposed staff are appropriate 
for executing the project activities. (10 points)

5. Capacity

    a. The degree to which organization demonstrates expertise in 
representing both the security and health aspects of a broad range of 
correctional facilities and activities (e.g., pre-release). (15 points)
    b. Evidence of experience/history working with corrections in 
health, security, education, and training of inmates and staff. (15 
points)

6. Budget

    The degree to which the budget is reasonable, clearly justified, 
and consistent with the intended use of funds. (Not scored)

7 . Human Subjects

    Does the application adequately address the requirements of 45 CFR 
part 46 for the protection of human subjects? (Not Scored)

____ YES ____ NO

Comments:--------------------------------------------------------------

H. Other Requirements

    Technical Reporting Requirements
    Provide CDC with original plus two copies of
    1. Quarterly Progress reports;
    2. Financial status report, no more than 90 days after the end of 
the budget period; and
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.

[[Page 31226]]

    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.
    The following additional requirements are applicable to this 
program. For a complete description of each, see Attachment I in the 
application kit.

AR-1  Human Subjects Requirement
AR-2  Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-7  Executive Order 12372 Review
AR-9  Paperwork Reduction Act Requirements
AR-10  Smoke-Free Workplace Requirements
AR-11  Healthy People 2000
AR-12  Lobbying Restrictions
AR-15  Proof of Non-Profit Status

I. Authority and Catalog of Federal Domestic

    Assistance Number
    This program is authorized under sections 301(a) and 317(k)(1)of 
the Public Health Service Act, (42 U.S.C. sections 247b(k)(1) and 
247b(k)(2)), as amended. The Catalog of Federal Domestic Assistance 
(CFDA) number is 93.283.

J. Where To Obtain Additional Information

    To receive additional written information and to request an 
application kit, call 1-888-GRANTS4 (1-888-472-6874). You will be asked 
to leave you name and address and will be instructed to identify the 
Announcement number of interest.
    If you have questions after reviewing the contents of all the 
documents, business management technical assistance may be obtained 
from: Locke Thompson, Grants Management Specialist, Grants Management 
Branch, Procurement and Grants Office, Centers for Disease Control and 
Prevention (CDC), Room 3000, 2920 Brandywine Road, Atlanta, GA 30341-
4146, Telephone: (404) 842-2749, Email address: [email protected].
    See also the CDC homepage on the Internet to obtain a copy of this 
announcement: http://www.cdc.gov
    For program technical assistance, contact: Linda Moyer, Centers for 
Disease Control and Prevention, National Center for Infectious 
Diseases, Division of Rickettsial Diseases, Hepatitis Branch, 1600 
Clifton Rd, NE., Atlanta, GA 30333, Telephone: (404) 639-2709, E-mail 
address: [email protected].

    Dated: June 4, 1999.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 99-14700 Filed 6-9-99; 8:45 am]
BILLING CODE 4163-18-P